Kerbside

PROFITABLE DOSE

JUBILANT LIFE SCIENCES | BSE CODE: 530019 | CMP: Rs.160

Drug firm Jubilant Life Sciences has received final approvals from the US health regulator for its generics Mycophenolate Mofetil, an immuno-suppressant, and Rizatriptan, used for treatment of migraine, in the American market and also for anti-hypertensive Valsartan tablets. Therefore in past few trading session stock has been move higher side with large volume. Market source suggest that there is still some steam left in the counter, hence might potentially be on uptrend.

HIGH VOLTAGE

UJAAS ENERGY | BSE CODE: 532391 | CMP: Rs.22

The stock has witnessed a bounce back in the last few trading session. It has exposure to the solar power segment (both operations and turnkey projects) and has seen a bull-run on expectation that the Modi government would implement the successful Gujarat solar-power model elsewhere, too. It has been heard that the stock price is likely to witness more northward in upcoming days. The stock can be looked at from a short-term perspective.

CAPITAL GAINS

TIMKEN INDIA | BSE CODE: 522113 | CMP: Rs.504

The stock has witnessed a minor correction in the immediate near term mainly due to selling by FIIs which has been completely absorbed by DII. Historically the stock has been on a run-up, as there has been a sharp improvement in its financial performance; it has achieved its FY14 full year profit in just 6MFY15. The uptrend is expected to continue as the interest among DII is increasing.

HIGH YIELDING

RCF | BSE CODE: 524230 | CMP: Rs.67

Though the stock has been moving in the range of Rs 65-70 for the last one month, it has seen run-up with huge volumes (towards the close of this issue). The stock has seen renewed interest among FIIs, who have increased their exposure in last quarter. The momentum is expected to continue in the stock, due to the expected policy action in the fertiliser industry by the central government.